期刊文献+

阿仑膦酸钠在钙性尿毒症性小动脉病治疗中的应用 被引量:1

The efficacy of alendronate on the treatment of calcificuraemic arteriolopathy
原文传递
导出
摘要 钙性尿毒症性小动脉病(CUA),又称为钙化防御(Calciphylaxis),是一种慢性肾脏疾病(CKD)患者所特有的疾病,其病因为小血管钙化引起皮肤组织网状紫斑、破溃、坏死。CUA在血液透析患者中的发病率为4%,其病死率高达60%~80%,预后不良。我院应用阿仑膦酸钠治疗CUA患者9例,现报道如下并复习文献,探讨双磷酸盐在CUA治疗中的作用。一。
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第7期764-765,共2页 Chinese Journal of Geriatrics
关键词 二膦酸盐类 尿毒症 Diphosponates Uremia
  • 相关文献

参考文献10

  • 1Rogers NM,Coates PT. Calcific uraemicarteriolopathy :an update. Curr Opin NephrolHypertens,2008,17 :629-634.
  • 2Ong S,Coulson IH,Diagnosis and treatment ofcalciphylaxis. Skinmed,2012,10:166-170.
  • 3Wilmer WA,Magro CM. Calciphylaxis:emergingconcepts in prevention,diagnosis,and treatment.Semin Dial,2002 ,15 :172-186.
  • 4Toussaint ND,Elder GJ,Kerr PG. Bisphosphonatesin chronic kidney disease; balancing potential benefitsand adverse effects on bone and soft tissue. Clin JAm Soc Nephrol,2009,4:221-233.
  • 5刘胜,张晓英.老年人慢性肾功能衰竭的诊治[J].中华老年医学杂志,2006,25(3):236-238. 被引量:12
  • 6Price PA,Faus SA,Williamson MK.Bisphosphonates alendronate and ibandronate inhibitartery calcification at doses comparable to those thatinhibit bone resorption. Arterioscler Thromb VaseBiol,2001,21:817-824.
  • 7Monney P,Nguyen QV,Perroud H,et al. Rapidimprovement of calciphylaxis after intravenouspamidronate therapy in a patient with chronic renalfailure. Nephrol Dial Transplant,2004,19:2130-2132.
  • 8Schliep S,Schuler G,Kiesewetter F. Successfultreatment of calciphylaxis with pamidronate. Eur JDermatol,2008,18:554-556.
  • 9Torregrosa JV,Duran CE,Barros X,et al.Successful treatment of calcific uraemic arteriolopathywith bisphosphonates. Nefrologia,2012,32:329-334.
  • 10Miller PD. Is there a role for bisphosphonates inchronic kidney disease? Semin Dial,2007,20:186-190.

共引文献11

同被引文献16

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部